Company · CIK 0001750019 · SIC 2836 — Biological Products, (No Diagnostic Substances)
TCR2 THERAPEUTICS INC. · TCRR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2019 PForm 4 → | Feb 21, 6:06 pm EST | UBS Oncology Impact Fund L.P. +310% Owner | 666,667 | $15.00 | $10,000,005 | 3,370,982 | +24.7% | plan? |
| Feb 19, 2019 CForm 4 → | Feb 21, 6:06 pm EST | UBS Oncology Impact Fund L.P. +310% Owner | 2,704,315 | — | — | 2,704,315 | — | plan? |
| Feb 19, 2019 PForm 4 → | Feb 21, 6:05 pm EST | MPM SunStates Fund, L.P. +310% Owner | 706,666 | $15.00 | $10,599,990 | 4,050,865 | +21.1% | plan? |
| Feb 19, 2019 CForm 4 → | Feb 21, 6:05 pm EST | MPM SunStates Fund, L.P. +310% Owner | 3,148,297 | — | — | 3,344,199 | — | plan? |
| Feb 19, 2019 PForm 4 → | Feb 21, 6:05 pm EST | MPM BioVentures 2014, L.P. +710% Owner | 706,666 | $15.00 | $10,599,990 | 4,050,865 | +21.1% | plan? |
| Feb 19, 2019 CForm 4 → | Feb 21, 6:05 pm EST | MPM BioVentures 2014, L.P. +710% Owner | 3,148,297 | — | — | 3,344,199 | — | plan? |
| Feb 19, 2019 PForm 4 → | Feb 21, 5:01 pm EST | Morana Jovan-Embiricos +9Director, 10% Owner | 666,667 | $15.00 | $10,000,005 | 536,962 | — | plan? |
| Feb 19, 2019 CForm 4 → | Feb 21, 5:01 pm EST | Morana Jovan-Embiricos +9Director, 10% Owner | 2,904,594 | — | — | 403,629 | — | plan? |
| Feb 19, 2019 PForm 4 → | Feb 21, 4:54 pm EST | Upnorth Investment Ltd +210% Owner | 200,000 | $15.00 | $3,000,000 | 2,137,419 | +10.3% | plan? |
| Feb 19, 2019 CForm 4 → | Feb 21, 4:54 pm EST | Upnorth Investment Ltd +210% Owner | 1,937,419 | — | — | 1,937,419 | — | plan? |
| Feb 19, 2019 PForm 4 → | Feb 21, 4:52 pm EST | Ansbert GadickeDirector, 10% Owner | 1,373,333 | $15.00 | $20,599,995 | 1,569,235 | +701% | plan? |
| Feb 19, 2019 CForm 4 → | Feb 21, 4:52 pm EST | Ansbert GadickeDirector, 10% Owner | 5,852,612 | — | — | 2,704,315 | — | plan? |
| Feb 19, 2019 CForm 4 → | Feb 21, 4:50 pm EST | Neil W GibsonDirector | 706,351 | — | — | 706,351 | — | plan? |
| Feb 19, 2019 CForm 4 → | Feb 21, 4:19 pm EST | Redmile Group, LLC +110% Owner | 807,256 | — | — | 807,256 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 19, 2019 CForm 4 → | Feb 21, 6:06 pm EST | UBS Oncology Impact Fund L.P. +310% Owner | 16,750,000 | — | — | 0 | — | |
| Feb 19, 2019 CForm 4 → | Feb 21, 6:05 pm EST | MPM SunStates Fund, L.P. +310% Owner | 19,500,000 | — | — | 0 | — | |
| Feb 19, 2019 CForm 4 → | Feb 21, 6:05 pm EST | MPM BioVentures 2014, L.P. +710% Owner | 19,500,000 | — | — | 0 | — | |
| Feb 19, 2019 CForm 4 → | Feb 21, 5:01 pm EST | Morana Jovan-Embiricos +9Director, 10% Owner | 17,990,501 | — | — | 0 | — | |
| Feb 19, 2019 CForm 4 → | Feb 21, 4:54 pm EST | Upnorth Investment Ltd +210% Owner | 12,000,000 | — | — | 0 | — | |
| Feb 19, 2019 CForm 4 → | Feb 21, 4:52 pm EST | Ansbert GadickeDirector, 10% Owner | 36,250,000 | — | — | 0 | — | |
| Feb 19, 2019 CForm 4 → | Feb 21, 4:50 pm EST | Neil W GibsonDirector | 4,375,000 | — | — | 0 | — | |
| Feb 19, 2019 CForm 4 → | Feb 21, 4:19 pm EST | Redmile Group, LLC +110% Owner | 5,000,000 | — | — | 0 | — |